跳至主要内容
临床试验/NL-OMON55507
NL-OMON55507招募中2 期

A randomised, double-blind, controlled trial to evaluate the effects of a nutritional product on brain integrity in preterm infants - NutriBrain

utricia0 个研究点目标入组 98 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
98

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 0(—)

入选标准

  • - Gestational age of 24+0 to <30+0 weeks (by the best estimate of expected
  • date of delivery)
  • - Less than 72 hours old, and the intention to receive the first administration
  • of study product between 48-72 hours after birth
  • - Written informed consent from custodial parent(s)

排除标准

  • - Any relevant proven or suspected chromosomal anomaly, metabolic disorder,
  • genetic syndrome or congenital central nervous system malformation
  • - Presence of a congenital central nervous system infection
  • - Presence of any gastrointestinal malformation
  • - No realistic prospect of survival
  • - Concomitant participation in other intervention studies (for example, but not
  • exclusively, those studies involving investigational or marketed nutritional or
  • pharmaceutical products) that could impact on the main outcome parameters
  • and/or subject safety
  • - Expected or foreseen inability of the subject and/or their families to adhere
  • to protocol instructions
  • - Admission from an extra regional hospital, unless that hospital is a study
  • - Currrent use of gastric inhibitors: H2-receptor antagonists (including
  • ranitidine) or proton pump inhibitors (including omeprazole)

研究者

发起方
utricia

相似试验